Guggenheim initiated coverage of Assembly Biosciences (ASMB) with a Buy rating and $31 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Disclaimer & DisclosureReport an Issue